 |
5-[4-[2-(5-(1-hydroxyethyl)-2-pyridinyl)ethoxy]benzyl]-2,4-thiazolidinedione hydrochloride |
|---|---|
| Trade Name | |
| Orphan Indication | X-linked adrenoleukodystrophy |
| EU Market Approval | EU |
| EU Designation Date | 2016-11-18 00:00:00 |
| Sponsor | Minoryx Therapeutics S.L. |
| |
5-[4-[2-(5-(1-hydroxyethyl)-2-pyridinyl)ethoxy]benzyl]-2,4-thiazolidinedione hydrochloride |
|---|---|
| Trade Name | |
| Orphan Indication | X-linked adrenoleukodystrophy |
| EU Market Approval | EU |
| EU Designation Date | 2016-11-18 00:00:00 |
| Sponsor | Minoryx Therapeutics S.L. |